Current Cardiology Reports

, 13:357

Review of the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Trial: Warfarin Versus Dabigatran

Authors

  • Christopher Ingelmo
    • Director of Cardiac EP OPD, Director Research DevelopmentCleveland Clinic Foundation
    • Director of Cardiac EP OPD, Director Research DevelopmentCleveland Clinic Foundation
Clinical Trial Report

DOI: 10.1007/s11886-011-0203-4

Cite this article as:
Ingelmo, C. & Wazni, O. Curr Cardiol Rep (2011) 13: 357. doi:10.1007/s11886-011-0203-4

Keywords

Atrial fibrillationWarfarinDabigatranRE-LY trialAnticoagulation therapy

Copyright information

© Springer Science+Business Media, LLC 2011